Oxford Biomedica plc (LON:OXB)
London
· Delayed Price · Currency is GBP · Price in GBX 615.00
-9.00 (-1.44%)
At close: Mar 9, 2026
Oxford Biomedica Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 754 | 445 | 213 | 426 | 1,059 | 848 | Upgrade
|
| Market Cap Growth | 112.46% | 108.92% | -50.00% | -59.79% | 24.98% | 71.01% | Upgrade
|
| Enterprise Value | 806 | 479 | 223 | 453 | 1,008 | 808 | Upgrade
|
| Last Close Price | 6.24 | 4.20 | 2.20 | 4.42 | 12.30 | 10.30 | Upgrade
|
| PE Ratio | - | - | - | - | 55.72 | - | Upgrade
|
| Forward PE | - | - | - | - | 60.29 | - | Upgrade
|
| PS Ratio | 4.99 | 3.46 | 2.38 | 3.04 | 7.42 | 9.66 | Upgrade
|
| PB Ratio | 23.05 | 7.36 | 2.74 | 1.80 | 5.66 | 7.52 | Upgrade
|
| P/TBV Ratio | 89.67 | 15.99 | 4.95 | 4.31 | 5.66 | 7.52 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 66.23 | - | Upgrade
|
| P/OCF Ratio | - | - | - | - | 41.62 | 272.03 | Upgrade
|
| EV/Sales Ratio | 5.33 | 3.72 | 2.49 | 3.24 | 7.06 | 9.21 | Upgrade
|
| EV/EBITDA Ratio | - | - | - | - | 30.85 | 224.65 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 45.53 | - | Upgrade
|
| EV/FCF Ratio | -66.99 | - | - | - | 63.01 | - | Upgrade
|
| Debt / Equity Ratio | 3.22 | 1.80 | 1.43 | 0.48 | 0.05 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | - | - | - | - | 0.27 | 2.78 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.58 | - | Upgrade
|
| Net Debt / Equity Ratio | 1.58 | 0.80 | 0.10 | -0.11 | -0.53 | -0.29 | Upgrade
|
| Net Debt / EBITDA Ratio | -4.10 | -2.30 | -0.11 | 0.87 | -3.05 | -9.22 | Upgrade
|
| Net Debt / FCF Ratio | -4.28 | -0.83 | -0.20 | 0.93 | -6.23 | 3.24 | Upgrade
|
| Asset Turnover | 0.66 | 0.53 | 0.25 | 0.40 | 0.68 | 0.57 | Upgrade
|
| Inventory Turnover | 5.25 | 5.73 | 3.91 | 6.40 | 7.32 | 8.78 | Upgrade
|
| Quick Ratio | 1.59 | 1.98 | 2.80 | 3.33 | 4.54 | 1.88 | Upgrade
|
| Current Ratio | 1.89 | 2.28 | 3.19 | 3.61 | 4.92 | 2.06 | Upgrade
|
| Return on Equity (ROE) | -75.20% | -70.28% | -117.29% | -21.32% | 12.67% | -6.63% | Upgrade
|
| Return on Assets (ROA) | -7.44% | -9.76% | -15.07% | -8.33% | 6.57% | -1.98% | Upgrade
|
| Return on Invested Capital (ROIC) | -32.56% | -38.94% | -58.29% | -31.30% | 25.31% | -6.72% | Upgrade
|
| Return on Capital Employed (ROCE) | -18.70% | -21.80% | -41.30% | -11.60% | 10.90% | -3.70% | Upgrade
|
| Earnings Yield | -4.91% | -9.71% | -73.95% | -9.19% | 1.80% | -0.74% | Upgrade
|
| FCF Yield | -1.59% | -13.07% | -18.01% | -6.79% | 1.51% | -1.21% | Upgrade
|
| Buyback Yield / Dilution | -2.96% | -7.15% | -1.82% | -10.76% | -7.10% | -9.95% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.